Latest News

Drs. Feldman and Goutman
March 2, 2020

Voicing the Need for ALS Environmental Research

Drs. Feldman and Goutman call for action to study how the environment influences ALS risk and progression in a JAMA Neurology article. Dr. Feldman recently received a $2.5 million grant from the NIH to examine the ties between genetics and the environment.

group photo of PNRD 2018
December 12, 2019

Dr. Feldman Reviews 2019 Accomplishments

In 2019, our laboratory made discoveries in diabetes, Alzheimer's disease and ALS, which resulted in 21 scientific manuscripts. 2020 will mark the 20th anniversary of the Program for Neurology Research & Discovery.

World Diabetes Day
November 14, 2019

World Diabetes Day 2019—Dr. Eva Feldman Shares Its Importance

Diabetes has reached epidemic proportions. In the United States, over 30 million people have diabetes, while another 85 million have prediabetes. These numbers are projected to increase at the rate of 5% per year. At this pace, more than one in three Americans born after 2000 will develop diabetes in their lifetime.

Eva Feldman, M.D., Ph.D., at ANA 2019
October 18, 2019

Eva Feldman, M.D., Ph.D., Reflects on ANA 2019

Dr. Eva Feldman discusses the great impact that the American Neurological Association has had on her career. She served as ANA President from 2011-13 and believes that it is the home for all academic neurologists, both established and emerging.

Pages